Kathryn Puxty1, Philip McLoone2, Tara Quasim1, Billy Sloan2, John Kinsella1, David S Morrison2. 1. Anaesthesia and Intensive Care, School of Medicine, Glasgow Royal Infirmary, Glasgow, Scotland. 2. West of Scotland Cancer Surveillance Unit, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.
Abstract
IMPORTANCE: Critical illness may be a potential determinant of cancer outcomes and geographic variations, but its role has not been described before. OBJECTIVE: To determine the incidence of admission to intensive care units (ICUs) within 2 years following cancer diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective observational study using cancer registry data in 4 datasets from 2000 to 2009 with linked ICU admission data from 2000 to 2011, in the West of Scotland region of the United Kingdom (population, 2.4 million; all 16 ICUs within the region). All 118,541 patients (≥16 years) diagnosed as having solid (nonhematological) cancers. Their median age was 69 years, and 52.0% were women. MAIN OUTCOMES AND MEASURES: Demographic and clinical variables associated with admission to an ICU and death in an ICU. RESULTS: A total of 118,541 patients met the study criteria. Overall, 6116 patients (5.2% [95% CI, 5.0%-5.3%]) developed a critical illness and were admitted to an ICU within 2 years. Risk of critical illness was highest at ages 60 to 69 years and higher in men. The cumulative incidence of critical illness was greatest for small intestinal (17.2% [95% CI, 13.3%-21.8%]) and colorectal cancers (16.5% [95% CI, 15.9%-17.1%]). The risk following breast cancer was low (0.8% [95% CI, 0.7%-1.0%]). The percentage who died in ICUs was 14.1% (95% CI, 13.3%-15.0%), and during the hospital stay, 24.6% (95% CI, 23.5%-25.7%). Mortality was greatest among emergency medical admissions and lowest among elective surgical patients. The risk of critical illness did not vary by socioeconomic circumstances, but mortality was higher among patients from deprived areas. CONCLUSIONS AND RELEVANCE: In this study, about 1 in 20 patients experienced a critical illness resulting in ICU admission within 2 years of cancer diagnosis. The associated high mortality rate may make a significant contribution to overall cancer outcomes.
IMPORTANCE: Critical illness may be a potential determinant of cancer outcomes and geographic variations, but its role has not been described before. OBJECTIVE: To determine the incidence of admission to intensive care units (ICUs) within 2 years following cancer diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective observational study using cancer registry data in 4 datasets from 2000 to 2009 with linked ICU admission data from 2000 to 2011, in the West of Scotland region of the United Kingdom (population, 2.4 million; all 16 ICUs within the region). All 118,541 patients (≥16 years) diagnosed as having solid (nonhematological) cancers. Their median age was 69 years, and 52.0% were women. MAIN OUTCOMES AND MEASURES: Demographic and clinical variables associated with admission to an ICU and death in an ICU. RESULTS: A total of 118,541 patients met the study criteria. Overall, 6116 patients (5.2% [95% CI, 5.0%-5.3%]) developed a critical illness and were admitted to an ICU within 2 years. Risk of critical illness was highest at ages 60 to 69 years and higher in men. The cumulative incidence of critical illness was greatest for small intestinal (17.2% [95% CI, 13.3%-21.8%]) and colorectal cancers (16.5% [95% CI, 15.9%-17.1%]). The risk following breast cancer was low (0.8% [95% CI, 0.7%-1.0%]). The percentage who died in ICUs was 14.1% (95% CI, 13.3%-15.0%), and during the hospital stay, 24.6% (95% CI, 23.5%-25.7%). Mortality was greatest among emergency medical admissions and lowest among elective surgical patients. The risk of critical illness did not vary by socioeconomic circumstances, but mortality was higher among patients from deprived areas. CONCLUSIONS AND RELEVANCE: In this study, about 1 in 20 patients experienced a critical illness resulting in ICU admission within 2 years of cancer diagnosis. The associated high mortality rate may make a significant contribution to overall cancer outcomes.
Authors: Elie Azoulay; Peter Pickkers; Marcio Soares; Anders Perner; Jordi Rello; Philippe R Bauer; Andry van de Louw; Pleun Hemelaar; Virginie Lemiale; Fabio Silvio Taccone; Ignacio Martin Loeches; Tine Sylvest Meyhoff; Jorge Salluh; Peter Schellongowski; Katerina Rusinova; Nicolas Terzi; Sangeeta Mehta; Massimo Antonelli; Achille Kouatchet; Andreas Barratt-Due; Miia Valkonen; Precious Pearl Landburg; Fabrice Bruneel; Ramin Brandt Bukan; Frédéric Pène; Victoria Metaxa; Anne Sophie Moreau; Virginie Souppart; Gaston Burghi; Christophe Girault; Ulysses V A Silva; Luca Montini; François Barbier; Lene B Nielsen; Benjamin Gaborit; Djamel Mokart; Sylvie Chevret Journal: Intensive Care Med Date: 2017-09-25 Impact factor: 17.440
Authors: Sarah Morin; Adeline Grateau; Danielle Reuter; Eric de Kerviler; Constance de Margerie-Mellon; Cédric de Bazelaire; Lara Zafrani; Benoit Schlemmer; Elie Azoulay; Emmanuel Canet Journal: Support Care Cancer Date: 2017-08-24 Impact factor: 3.603
Authors: Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares Journal: Intensive Care Med Date: 2017-07-19 Impact factor: 17.440
Authors: David J Shaz; Stephen M Pastores; Debra A Goldman; Natalie Kostelecky; Richard F Tizon; Kay See Tan; Neil A Halpern Journal: Support Care Cancer Date: 2019-12-14 Impact factor: 3.603
Authors: Andrew S Epstein; Andrew Yang; Lauren E Colbert; Louis P Voigt; Jason Meadows; Jessica I Goldberg; Leonard B Saltz Journal: J Intensive Care Med Date: 2017-12-20 Impact factor: 3.510